MedTrace Logo

RELAXaHEAD for Headache Patients (Phase III)

NCT06077838 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2025-10-10

No results posted yet for this study

Summary

This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.

Conditions

Interventions

BEHAVIORAL

RELAXaHEAD Smartphone App Version 1

RELAXaHEAD is a smartphone application that allows users to track headache frequency and severity, sleep, medication, medication side effects, and menstrual cycle, and create personal notes daily. The RELAXaHEAD app has an option for users to view their data reports and charts.

BEHAVIORAL

RELAXaHEAD Smartphone App Version 2

RELAXaHEAD is a smartphone application that allows users to track headache frequency and severity, sleep, medication, medication side effects, and menstrual cycle, and create personal notes daily. The RELAXaHEAD app has an option for users to view their data reports and charts. This version also contains audio materials.

Sponsors & Collaborators

Principal Investigators

  • Mia T Minen, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2028-08-31
Completion
2028-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077838 on ClinicalTrials.gov